Cargando…

Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics

BACKGROUND: The antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (HCC) in patients with liver cirrhosis. It might also be effective in noncirrhotic HCC provided that the angiogenic properties of both tumor types are comparable. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Wenjiao, Gouw, Annette S. H., van den Heuvel, Marius C., Molema, Grietje, Poppema, Sibrand, van der Jagt, Eric J., de Jong, Koert P.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Hepatobiliary Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868164/ https://www.ncbi.nlm.nih.gov/pubmed/20087783 http://dx.doi.org/10.1245/s10434-009-0900-z

Ejemplares similares

Correlation of MicroRNA-16, MicroRNA-21 and MicroRNA-101 Expression with Cyclooxygenase-2 Expression and Angiogenic Factors in Cirrhotic and Noncirrhotic Human Hepatocellular Carcinoma
por: Zeng, Wenjiao, et al.
Publicado: (2014)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

Real-Time Wireless Tumor Tracking in Navigated Liver Resections: An Ex Vivo Feasibility Study
por: Eppenga, Roeland, et al.
Publicado: (2022)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis
por: van Kessel, Charlotte S., et al.
Publicado: (2012)

The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
por: Grąt, Michał, et al.
Publicado: (2016)

Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma
por: Grąt, Michał, et al.
Publicado: (2019)

Does Viral Hepatitis Status Relate to Hepatocellular Carcinoma After Liver Resection?
por: Yi, Xiaoling, et al.
Publicado: (2023)

Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
por: Grąt, Michał, et al.
Publicado: (2017)

The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study
por: Rasic, Gordana, et al.
Publicado: (2023)

Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease
por: de Savornin Lohman, Elise A. J., et al.
Publicado: (2019)

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
por: Bond, Marinde J. G., et al.
Publicado: (2023)

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands
por: Buisman, Florian E., et al.
Publicado: (2019)

Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma
por: Chu, Tongjia, et al.
Publicado: (2022)

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
por: Zhu, Xiao-Dong, et al.
Publicado: (2022)

Risk Factors of Peritoneal Recurrence and Outcome of Resected Peritoneal Recurrence After Liver Resection in Hepatocellular Carcinoma: Review of 1222 Cases of Hepatectomy in a Tertiary Institution
por: Kow, Alfred Wei Chieh, et al.
Publicado: (2012)

Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort Study
por: Liu, Fusheng, et al.
Publicado: (2023)

Upregulation of Protein Tyrosine Phosphatase Type IVA Member 3 (PTP4A3/PRL-3) is Associated with Tumor Differentiation and a Poor Prognosis in Human Hepatocellular Carcinoma
por: Mayinuer, Abudureheman, et al.
Publicado: (2012)

The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy
por: Filipe, W. F., et al.
Publicado: (2023)

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study
por: Ruys, Anthony T., et al.
Publicado: (2011)

Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study
por: Kuipers, H., et al.
Publicado: (2020)

Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon
por: Burra, Patrizia, et al.
Publicado: (2022)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

The Landmark Series: Minimally Invasive Pancreatic Resection
por: van Hilst, Jony, et al.
Publicado: (2020)

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis
por: Galjart, Boris, et al.
Publicado: (2016)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis
por: Klompmaker, Sjors, et al.
Publicado: (2019)

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group
por: Ruzzenente, Andrea, et al.
Publicado: (2021)

The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma
por: van Keulen, Anne-Marleen, et al.
Publicado: (2023)

Mini-Mesohepatectomy for Colorectal Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence: Educational Video Demonstrating IOUS Use in Modern Hepatic Surgery
por: Makuuchi, Masatoshi, et al.
Publicado: (2009)

Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases
por: de Haas, Robbert J., et al.
Publicado: (2010)

Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases
por: Wicherts, Dennis A., et al.
Publicado: (2010)

Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
por: Robinson, Stuart M., et al.
Publicado: (2012)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
por: Ariizumi, Shun-ichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ll2jbos0s9bl5f80vek231qthc